You will be able to find all of our recent and archived news announcements. Our press releases are intended for business journalists and analysts/investors.
GSK to divest ofatumumab for auto-immune indications to Novartis for up to $1 billion plus royalties
GlaxoSmithKline plc (LSE/NYSE: GSK) today announced an agreement with Novartis Pharma AG (“Novartis Pharma”), a subsidiary of Novartis AG, to divest its rights in ofatumumab for auto-immune indications, including multiple sclerosis.
GSK delivers Q2 Group sales of £5.9 billion +7% CER and core EPS of 17.3p (flat CER) in first full quarter of performance since transaction
GSK today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for the expansion of the SynflorixTM European label
GSK’s malaria candidate vaccine, Mosquirix™ (RTS,S), receives positive opinion from European regulators for the prevention of malaria in young children in sub-Saharan Africa
GSK announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive scientific opinion for its malaria candidate vaccine Mosquirix.
GSK and Save the Children launch 2015 call for developing country healthcare innovations to reduce child deaths
GSK and Save the Children announce the launch of their third annual $1 million Healthcare Innovation Award that rewards innovations in healthcare that have helped to reduce child deaths in developing countries.
GSK and the Francis Crick Institute join forces in collaboration to forge new scientific discoveries
The Francis Crick Institute, the UK’s newest biomedical research facility, and GSK, the UK’s largest pharmaceutical company, are to partner on an open innovation collaboration exploring new avenues of medical research and drug discovery across a broad range of diseases, with a view to achieving breakthroughs in the understanding of human disease
GlaxoSmithKline plc (LSE/NYSE: GSK) is divesting its meningitis vaccines Nimenrix and Mencevax to Pfizer Ireland Pharmaceuticals (a subsidiary of Pfizer Inc).
GSK to create independent research institute with goal of radically changing and improving medicines development
Seattle-based Altius Institute for Biomedical Sciences to pioneer new understanding of cell “operating systems”
GSK announces outcome of US FDA Advisory Committee recommending approval of mepolizumab for the treatment of adults with severe asthma
GlaxoSmithKline plc (LSE: GSK) today announced the outcome of the meeting of the Pulmonary Allergy Drugs Advisory Committee of the United States (US) Food and Drug Administration (FDA) regarding the Biologics Licence Application (BLA) for mepolizumab as an add-on maintenance treatment for severe asthma with eosinophilic inflammation.
Explore more stories and features
Increasing access in India
We’ve embarked on a major initiative to ensure that our entire range of wellness, oral health, nutrition and food products are available even in the remotest villages.